Literature DB >> 9570493

Blood levels of cytokines in elderly patients with major depressive disorder.

F Brambilla1, M Maggioni.   

Abstract

Plasma concentrations of interleukin-1beta (IL-1beta), interleukin-6 (IL-6) and tumour necrosis factor alpha (TNFalpha) were measured in 10 elderly women with major depressive disorder (MDD) and in two groups of controls, one consisting of 10 age-matched healthy female volunteers and one consisting of 10 young healthy female volunteers. The cytokine concentrations were measured in MDD patients before and after 30 days of treatment with phosphatidylserine (BC-PS), 600 mg daily p.o. The plasma IL-Ibeta, IL-6 and TNFalpha concentrations did not differ significantly in young controls, elderly controls and MDD patients. BC-PS therapy, while significantly improving the depressive symptoms, did not alter the cytokine concentrations.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9570493     DOI: 10.1111/j.1600-0447.1998.tb10005.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  30 in total

Review 1.  Cytokine, sickness behavior, and depression.

Authors:  Robert Dantzer
Journal:  Neurol Clin       Date:  2006-08       Impact factor: 3.806

2.  Sustained low-grade pro-inflammatory state in unmedicated, remitted women with major depressive disorder as evidenced by elevated serum levels of the acute phase proteins C-reactive protein and serum amyloid A.

Authors:  Mitchel A Kling; Salvatore Alesci; Gyorgy Csako; Rene Costello; David A Luckenbaugh; Omer Bonne; Roman Duncko; Wayne C Drevets; Husseini K Manji; Dennis S Charney; Philip W Gold; Alexander Neumeister
Journal:  Biol Psychiatry       Date:  2006-12-18       Impact factor: 13.382

Review 3.  The inflammation hypothesis in geriatric depression.

Authors:  George S Alexopoulos; Sarah Shizuko Morimoto
Journal:  Int J Geriatr Psychiatry       Date:  2011-03-02       Impact factor: 3.485

4.  Neuroprotective phosphatidylserine liposomes alleviate depressive-like behavior related to stroke through neuroinflammation attenuation in the mouse hippocampus.

Authors:  Alireza Partoazar; Zahra Seyyedian; Golnaz Zamanian; Partow Mirzaee Saffari; Ahad Muhammadnejad; Ahmad Reza Dehpour; Ramin Goudarzi
Journal:  Psychopharmacology (Berl)       Date:  2021-02-11       Impact factor: 4.530

Review 5.  Inflammatory cytokine-associated depression.

Authors:  Francis E Lotrich
Journal:  Brain Res       Date:  2014-07-05       Impact factor: 3.252

6.  Alteration of immune markers in a group of melancholic depressed patients and their response to electroconvulsive therapy.

Authors:  Gavin Rush; Aoife O'Donovan; Laura Nagle; Catherine Conway; AnnMaria McCrohan; Cliona O'Farrelly; James V Lucey; Kevin M Malone
Journal:  J Affect Disord       Date:  2016-06-17       Impact factor: 4.839

7.  Cytokine, sickness behavior, and depression.

Authors:  Robert Dantzer
Journal:  Immunol Allergy Clin North Am       Date:  2009-05       Impact factor: 3.479

8.  Cytokine-induced depression during IFN-alpha treatment: the role of IL-6 and sleep quality.

Authors:  Aric A Prather; Mordechai Rabinovitz; Bruce G Pollock; Francis E Lotrich
Journal:  Brain Behav Immun       Date:  2009-07-15       Impact factor: 7.217

Review 9.  [Immunological aspects of depressive disorders].

Authors:  N Müller; M J Schwarz
Journal:  Nervenarzt       Date:  2007-11       Impact factor: 1.214

Review 10.  A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder.

Authors:  Rushaniya A Khairova; Rodrigo Machado-Vieira; Jing Du; Husseini K Manji
Journal:  Int J Neuropsychopharmacol       Date:  2009-02-19       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.